USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	066356/0108			Pages:	7
		Recorded:	01/19/2024
Attorney Dkt #:	137166-00001
Conveyance:	CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).

Total properties: 14

Patent #:	11066457	Issue Dt:	07/20/2021	Application #:	16484482	Filing Dt:	08/08/2019
Publication #:	US20200002400	Pub Dt:	01/02/2020
Title:	CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF

Patent #:	11207349	Issue Dt:	12/28/2021	Application #:	16877069	Filing Dt:	05/18/2020
Publication #:	US20210290673	Pub Dt:	09/23/2021
Title:	Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof

Patent #:	11472858	Issue Dt:	10/18/2022	Application #:	17352915	Filing Dt:	06/21/2021
Publication #:	US20210361710	Pub Dt:	11/25/2021
Title:	CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF

Patent #:	11439665	Issue Dt:	09/13/2022	Application #:	17475766	Filing Dt:	09/15/2021
Publication #:	US20220031752	Pub Dt:	02/03/2022
Title:	COMBINED CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD20 AND APPLICATION THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17721647	Filing Dt:	04/15/2022
Publication #:	US20220249568	Pub Dt:	08/11/2022
Title:	Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof

Patent #:	11618778	Issue Dt:	04/04/2023	Application #:	17723859	Filing Dt:	04/19/2022
Publication #:	US20220324940	Pub Dt:	10/13/2022
Title:	CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF

Patent #:	11633430	Issue Dt:	04/25/2023	Application #:	17750658	Filing Dt:	05/23/2022
Publication #:	US20220288123	Pub Dt:	09/15/2022
Title:	Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof

Patent #:	11608369	Issue Dt:	03/21/2023	Application #:	17750855	Filing Dt:	05/23/2022
Publication #:	US20220281945	Pub Dt:	09/08/2022
Title:	CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17831637	Filing Dt:	06/03/2022
Publication #:	US20220340640	Pub Dt:	10/27/2022
Title:	CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17911502	Filing Dt:	09/14/2022
Publication #:	US20230104705	Pub Dt:	04/06/2023
Title:	COMBINED CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD20 AND APPLICATION THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17911524	Filing Dt:	09/14/2022
Publication #:	US20230212255	Pub Dt:	07/06/2023
Title:	COMBINED CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD20 AND APPLICATIONS THEREOF

Patent #:	NONE	Issue Dt:		Application #:	18173187	Filing Dt:	02/23/2023
Publication #:	US20230242613	Pub Dt:	08/03/2023
Title:	CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF

Patent #:	NONE	Issue Dt:		Application #:	18183681	Filing Dt:	03/14/2023
Publication #:	US20240139243	Pub Dt:	05/02/2024
Title:	Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof

Patent #:	NONE	Issue Dt:		Application #:	18263050	Filing Dt:	07/26/2023
Publication #:	US20240115605	Pub Dt:	04/11/2024
Title:	CHIMERIC ANTIGEN RECEPTORS TARGETING CD20

Assignor

Exec Dt:

11/15/2023

Assignee

9605 MEDICAL CENTER DRIVE

SUITE 100

ROCKVILLE, MARYLAND 20850

Correspondence name and address
	MCCARTER & ENGLISH, LLP
	265 FRANKLIN STREET
	BOSTON, MA 02110

Search Results as of: 05/23/2024 12:23 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6